Literature DB >> 23088577

Decellularized tissue-engineered heart valve leaflets with recellularization potential.

Zeeshan H Syedain1, Allison R Bradee, Stefan Kren, Doris A Taylor, Robert T Tranquillo.   

Abstract

Tissue-engineered heart valves (TEHV) have been proposed as a promising solution for the clinical needs of pediatric patients. In vivo studies have shown TEHV leaflet contraction and regurgitation after several months of implantation. This has been attributed to contractile cells utilized to produce the extracellular matrix (ECM) during TEHV culture. Here, we utilized such cells to develop a mature ECM in a fibrin-based scaffold that generates commissural alignment in TEHV leaflets and then removed these cells using detergents. Further, we evaluated recellularization with potentially noncontractile cells. A tissue-engineered leaflet model was developed with mechanical anisotropy and tensile properties comparable to an ovine pulmonary valve leaflet. No change in tensile properties occurred after decellularization using 1% sodium dodecyl sulfate and 1% Triton detergent treatment. Cell removal was verified by DNA quantitation and western blot analysis for cellular proteins. Histological and scanning electron microscope imaging showed no significant change in the ECM organization and microstructure. We further tested the recellularization potential of decellularized leaflets by seeding human mesenchymal stem cells (hMSC) on the surface of the leaflets and evaluated them at 1 and 3 weeks in two culture conditions. One medium (M1) was chosen to maintain the MSC phenotype while a second medium (M2) was used to potentially differentiate cells to an interstitial cell phenotype. Cellular quantitation showed that the engineered leaflets were recellularized to the highest concentration with M2 followed by M1, with minimum cell invasion of decellularized native leaflets. Histology showed cellular invasion throughout the thickness of the leaflets in M2 and partial invasion in M1. hMSC stained positive for MSC markers, but also for α-smooth muscle actin in both media at 1 week, with no presence of MSC markers at 3 weeks with the exception of CD90. These results show that engineered leaflets, while having similar tensile properties and collagen content compared to native leaflets, have better recellularization potential.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23088577      PMCID: PMC3566676          DOI: 10.1089/ten.TEA.2012.0365

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  55 in total

1.  Functional living trileaflet heart valves grown in vitro.

Authors:  S P Hoerstrup; R Sodian; S Daebritz; J Wang; E A Bacha; D P Martin; A M Moran; K J Guleserian; J S Sperling; S Kaushal; J P Vacanti; F J Schoen; J E Mayer
Journal:  Circulation       Date:  2000-11-07       Impact factor: 29.690

2.  Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells.

Authors:  Dörthe Schmidt; Petra E Dijkman; Anita Driessen-Mol; Rene Stenger; Christine Mariani; Arja Puolakka; Marja Rissanen; Thorsten Deichmann; Bernhard Odermatt; Benedikt Weber; Maximilian Y Emmert; Gregor Zund; Frank P T Baaijens; Simon P Hoerstrup
Journal:  J Am Coll Cardiol       Date:  2010-08-03       Impact factor: 24.094

3.  Percutaneous pulmonary valve replacement: autologous tissue-engineered valved stents.

Authors:  Anja Metzner; Ulrich A Stock; Kenji Iino; Gunther Fischer; Tim Huemme; Jessica Boldt; Jan Hinrich Braesen; Berthold Bein; Jochen Renner; Jochen Cremer; Georg Lutter
Journal:  Cardiovasc Res       Date:  2010-07-01       Impact factor: 10.787

Review 4.  Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.

Authors:  Donald G Phinney; Darwin J Prockop
Journal:  Stem Cells       Date:  2007-09-27       Impact factor: 6.277

Review 5.  Tissue-engineered heart valve scaffolds.

Authors:  Pascal M Dohmen; Wolfgang Konertz
Journal:  Ann Thorac Cardiovasc Surg       Date:  2009-12       Impact factor: 1.520

6.  Cyclic distension of fibrin-based tissue constructs: evidence of adaptation during growth of engineered connective tissue.

Authors:  Zeeshan H Syedain; Justin S Weinberg; Robert T Tranquillo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-24       Impact factor: 11.205

7.  TGF-β1 diminishes collagen production during long-term cyclic stretching of engineered connective tissue: implication of decreased ERK signaling.

Authors:  Zeeshan H Syedain; Robert T Tranquillo
Journal:  J Biomech       Date:  2011-01-20       Impact factor: 2.712

8.  Tissue engineering of heart valves: in vitro experiences.

Authors:  R Sodian; S P Hoerstrup; J S Sperling; S H Daebritz; D P Martin; F J Schoen; J P Vacanti; J E Mayer
Journal:  Ann Thorac Surg       Date:  2000-07       Impact factor: 4.330

Review 9.  Heart valve tissue engineering.

Authors:  Ivan Vesely
Journal:  Circ Res       Date:  2005-10-14       Impact factor: 17.367

10.  Controlled compaction with ruthenium-catalyzed photochemical cross-linking of fibrin-based engineered connective tissue.

Authors:  Zeeshan H Syedain; Jason Bjork; Lillian Sando; Robert T Tranquillo
Journal:  Biomaterials       Date:  2009-09-25       Impact factor: 12.479

View more
  32 in total

1.  Functional Heart Valve Scaffolds Obtained by Complete Decellularization of Porcine Aortic Roots in a Novel Differential Pressure Gradient Perfusion System.

Authors:  Leslie Neil Sierad; Eliza Laine Shaw; Alexander Bina; Bryn Brazile; Nicholas Rierson; Sourav S Patnaik; Allison Kennamer; Rebekah Odum; Ovidiu Cotoi; Preda Terezia; Klara Branzaniuc; Harrison Smallwood; Radu Deac; Imre Egyed; Zoltan Pavai; Annamaria Szanto; Lucian Harceaga; Horatiu Suciu; Victor Raicea; Peter Olah; Agneta Simionescu; Jun Liao; Ionela Movileanu; Marius Harpa; Dan Teodor Simionescu
Journal:  Tissue Eng Part C Methods       Date:  2015-12       Impact factor: 3.056

Review 2.  How to make a heart valve: from embryonic development to bioengineering of living valve substitutes.

Authors:  Donal MacGrogan; Guillermo Luxán; Anita Driessen-Mol; Carlijn Bouten; Frank Baaijens; José Luis de la Pompa
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

3.  Pediatric tubular pulmonary heart valve from decellularized engineered tissue tubes.

Authors:  Jay M Reimer; Zeeshan H Syedain; Bee H T Haynie; Robert T Tranquillo
Journal:  Biomaterials       Date:  2015-05-16       Impact factor: 12.479

4.  JetValve: Rapid manufacturing of biohybrid scaffolds for biomimetic heart valve replacement.

Authors:  Andrew K Capulli; Maximillian Y Emmert; Francesco S Pasqualini; Debora Kehl; Etem Caliskan; Johan U Lind; Sean P Sheehy; Sung Jin Park; Seungkuk Ahn; Benedikt Weber; Josue A Goss; Simon P Hoerstrup; Kevin Kit Parker
Journal:  Biomaterials       Date:  2017-04-18       Impact factor: 12.479

5.  Trilayered tissue construct mimicking the orientations of three layers of a native heart valve leaflet.

Authors:  Soumen Jana; Amir Lerman
Journal:  Cell Tissue Res       Date:  2020-07-16       Impact factor: 5.249

6.  In vivo tissue engineering of a trilayered leaflet-shaped tissue construct.

Authors:  Soumen Jana; Amir Lerman
Journal:  Regen Med       Date:  2020-02-26       Impact factor: 3.806

7.  Decellularized periodontal ligament cell sheets with recellularization potential.

Authors:  A Farag; C Vaquette; C Theodoropoulos; S M Hamlet; D W Hutmacher; S Ivanovski
Journal:  J Dent Res       Date:  2014-09-30       Impact factor: 6.116

Review 8.  Immunogenicity in xenogeneic scaffold generation: antigen removal vs. decellularization.

Authors:  Maelene L Wong; Leigh G Griffiths
Journal:  Acta Biomater       Date:  2014-01-31       Impact factor: 8.947

Review 9.  Advances in the treatment of aortic valve disease: is it time for companion diagnostics?

Authors:  Robert B Hinton
Journal:  Curr Opin Pediatr       Date:  2014-10       Impact factor: 2.856

10.  6-month aortic valve implantation of an off-the-shelf tissue-engineered valve in sheep.

Authors:  Zeeshan Syedain; Jay Reimer; Jillian Schmidt; Matthew Lahti; James Berry; Richard Bianco; Robert T Tranquillo
Journal:  Biomaterials       Date:  2015-09-11       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.